Phytochemicals from MO demonstrated strong interactions with HIF-1α (hypoxia-inducible factor 1-alpha), VEGF, and GLUT1 receptors, showing favorable pharmacokinetics and potential as breast cancer inhibitors [260]. The gene discussed is HIF1A; the disease is breast cancer.